GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets
GLPG0634-CL-331
Phase 3 small_molecule active
Quick answer
GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets for Ulcerative colitis is a Phase 3 program (small_molecule) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alfasigma S.p.A.
- Indication
- Ulcerative colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active